Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 1/2 4Phase 2 3Phase 3 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3CNS 3

Conditions

Squamous Cell Carcinoma of Head and Neck 43Head and Neck Neoplasms 35Nasopharyngeal Carcinoma 19Oropharyngeal Neoplasms 17Carcinoma, Squamous Cell 15Rectal Neoplasms 13Carcinoma, Non-Small-Cell Lung 13Prostatic Neoplasms 11Esophageal Squamous Cell Carcinoma 11Mouth Neoplasms 8Esophageal Neoplasms 8Pancreatic Neoplasms 7Laryngeal Neoplasms 7Sarcoma 6Tongue Neoplasms 5Papillomavirus Infections 5Lung Neoplasms 5Hypopharyngeal Neoplasms 5Glioblastoma 5Brain Neoplasms 5Stomatitis 4Neoplasm Metastasis 4Nasopharyngeal Neoplasms 4Carcinoma 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Thyroid Carcinoma, Anaplastic 3Lymphatic Metastasis 3Gliosarcoma 3Glioma 3

Interventions

Temozolomide 46Radiotherapy 36Bevacizumab 34Carmustine 13Erlotinib Hydrochloride 11Irinotecan 10sargramostim 7Thalidomide 7Chemotherapy, Adjuvant 7Carboplatin 7Radiation 6pembrolizumab 5Topotecan 5Magnetic Resonance Spectroscopy 5Filgrastim 5Drug Therapy 5Cyclophosphamide 5aldesleukin 4Tamoxifen 4Surgical Procedures, Operative 4Sorafenib 4O(6)-benzylguanine 4Gefitinib 4Etoposide 4Celecoxib 4cediranib 3Radiotherapy, Intensity-Modulated 3Radiotherapy, Conformal 3Peripheral Blood Stem Cell Transplantation 3Imatinib Mesylate 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Gliosarcoma × Radiotherapy, Intensity-Modulated × Clear all
NCT01730950 2022-12-29

Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma

Radiation Therapy Oncology Group

Phase 2 Completed
182 enrolled 19 charts
CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT01062425 2022-07-26

Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma

National Cancer Institute (NCI)

Phase 2 Completed
261 enrolled 10 charts
CNSSarcoma

Glioblastoma, Gliosarcoma

NCT02394665 2017-01-05

Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma

University of Miami

Phase 2 Terminated
1 enrolled 3 charts
CNSSarcoma

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡